|
rs4374383
|
|
|
0.710 |
GeneticVariation |
BEFREE |
<i>MERTK</i> rs4374383 A carriers had a lower risk of liver fibrosis progression than G carriers, supporting the hypothesis that this SNP seems to have a critical role in the pathogenesis of liver disease in HCV-infected patients.
|
30477195 |
2018 |
|
rs4374383
|
|
A |
0.710 |
GeneticVariation |
GWASCAT |
In the combined cohort of 2342 HCV-infected patients, the SNPs rs16851720 (in the total sample) and rs4374383 (in patients who received blood transfusions) were associated with fibrosis progression (P(combined) = 8.9 × 10(-9) and 1.1 × 10(-9), respectively).
|
22841784 |
2012 |
|
rs116399066
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients.
|
31260374 |
2019 |
|
rs13401937
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients.
|
31260374 |
2019 |
|
rs1754257
|
|
A |
0.700 |
GeneticVariation |
GWASCAT |
Multi-Ancestry Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus.
|
30593799 |
2019 |
|
rs2492965
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients.
|
31260374 |
2019 |
|
rs2647006
|
|
C |
0.700 |
GeneticVariation |
GWASCAT |
Multi-Ancestry Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus.
|
30593799 |
2019 |
|
rs2647051
|
|
C |
0.700 |
GeneticVariation |
GWASCAT |
Multi-Ancestry Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus.
|
30593799 |
2019 |
|
rs35384524
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients.
|
31260374 |
2019 |
|
rs4803221
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients.
|
31260374 |
2019 |
|
rs56378326
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients.
|
31260374 |
2019 |
|
rs59888390
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients.
|
31260374 |
2019 |
|
rs62042908
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients.
|
31260374 |
2019 |
|
rs6445096
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients.
|
31260374 |
2019 |
|
rs72799981
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients.
|
31260374 |
2019 |
|
rs7332270
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients.
|
31260374 |
2019 |
|
rs74597329
|
|
T |
0.700 |
GeneticVariation |
GWASCAT |
Multi-Ancestry Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus.
|
30593799 |
2019 |
|
rs74597329
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients.
|
31260374 |
2019 |
|
rs75707332
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients.
|
31260374 |
2019 |
|
rs76755915
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients.
|
31260374 |
2019 |
|
rs76810409
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients.
|
31260374 |
2019 |
|
rs2856723
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Human leukocyte antigen variants and risk of hepatocellular carcinoma modified by hepatitis C virus genotypes: A genome-wide association study.
|
28921602 |
2018 |
|
rs11790131
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
A new 3p25 locus is associated with liver fibrosis progression in human immunodeficiency virus/hepatitis C virus-coinfected patients.
|
27339598 |
2016 |
|
rs143633948
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
A new 3p25 locus is associated with liver fibrosis progression in human immunodeficiency virus/hepatitis C virus-coinfected patients.
|
27339598 |
2016 |
|
rs35467001
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
A new 3p25 locus is associated with liver fibrosis progression in human immunodeficiency virus/hepatitis C virus-coinfected patients.
|
27339598 |
2016 |